Nasdaq

Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program

Las Vegas Nevada, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., (the “Company” “Odyssey”) a company focused on developing a unique drug ...
Seeking Alpha

Odyssey Health, Inc. Provides Recap on Concussion Drug Development

Las Vegas, Nevada, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (ODSY) (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical ...
Morningstar

Odyssey Therapeutics Appoints Dennis Dean, Ph.D., as Executive Vice President, Head of Non-Clinical Development

Veteran drug development leader brings decades of expertise in advancing programs from discovery to clinical stage Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to ...